Tessio Rebello

Health Technology

Consumer Services

Profile

Tessio Rebello is Vice President of Clinical Affairs for VIRxSYS Corp.
Prior to joining VIRxSYS, he served as Director of Clinical Development for United Therapeutics Corp.
and as Head of the Cardiovascular Division for Sigma-Tau Pharmaceuticals, Inc. Dr. Rebello received a Bachelor of Science degree from the University of Liverpool and a PhD from the University of London.

Former positions of Tessio Rebello

Companies	Position	End
VIRxSYS Corp. VIRxSYS Corp. BiotechnologyHealth Technology VIRxSYS Corp. is a holding company, which uses its proprietary platform technologies to develop therapies for serious human diseases. Its platform technologies include lentiviral vectors as a delivery vehicle for genes against certain diseases and for vaccine therapies. Its therapies are in various stages of development from pre-clinical through Phase II clinical trials. The company was founded by Boro Dropulic, William J. Turner, and Wiliam N. Sick Jr in 1998 and is headquartered in Gaithersburg, MD.	Chief Tech/Sci/R&D Officer	04/05/2014
Leadiant Biosciences, Inc. Leadiant Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Leadiant Biosciences, Inc. operates as a research-based pharmaceutical company. It develops and commercializes medicines for rare diseases. The company was founded in 1989 by Claudio Cavazza and is headquartered in Gaithersburg, MD.	Corporate Officer/Principal	-
UNITED THERAPEUTICS CORPORATION	President	21/05/2009

See the detail of Tessio Rebello's experience

Training of Tessio Rebello

The University of Liverpool	Undergraduate Degree
University of London	Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies